According to the 2021 WHO, they are classified into 3 groups; IDH-mutant astrocytoma, IDH-mutant and 1p/19q co-deleted oligodendroglioma, and IDH-wild type glioblastoma. This evidence concerns the gene IDH2 and oligodendroglioma.